Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Investor Presentations
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
Investor Presentations
7-Oct-2024
Investor webinar: Neuren continues PMS Phase 3 preparations following positive FDA meeting
19-Aug-2024
Investor roadshow presentation, 19 August 2024
9-Aug-2024
Investor webinar: NNZ-2591 Angelman syndrome Phase 2 trial top-line results
9-Aug-2024
NNZ-2591 Angelman top-line results presentation
29-May-2024
Corporate Presentation, 29 May 2024
28-May-2024
AGM webcast, 28 May 2024
28-May-2024
AGM Chair Address & CEO Presentation
27-May-2024
Investor webinar - Pitt Hopkins Phase 2 results, 27 May 2024
27-May-2024
Pitt Hopkins Phase 2 results presentation, 27 May 2024
15-May-2024
Investor presentation, 15 May 2024
1-Mar-2024
Investor webinar, 29 February 2024
18-Dec-2023
Investor web conference, 18 December 2023
18-Dec-2023
Investor presentation, 18 December 2023
8-Nov-2023
Investor presentation, 8 November 2023
29-Aug-2023
Investor web conference, 28 August 2023
28-Aug-2023
Investor presentation, 28 August 2023
14-Jul-2023
Investor web conference, 14 July 2023
5-Jun-2023
Jefferies Global Healthcare Conference, 8 June 2023
2-Jun-2023
AGM webcast, 30 May 2023
30-May-2023
AGM Chair Address & CEO Presentation
17-Mar-2023
Investor webinar, 14 March 2023
7-Dec-2022
MST Financial: Late Stage Biotech Forum, 30 Nov 2022
29-Nov-2022
Bell Potter Healthcare Conference, 8 Nov 2022
30-May-2022
AGM Chairman's Address & CEO Presentation
25-Feb-2022
Investor webinar, 25 February 2022
29-Jun-2021
MST Access Australian Micro & Small Caps Conference 2021 15 June 2021